Exxon Mobil drops as crude prices slide sharply on Strait of Hormuz reopening headlines

Exxon Mobil Corporation (XOM) is down 5.6% today. Here is some analysis on what might have caused this price movement.

Analysis: XOM is trading lower alongside the broader energy complex after crude oil prices fell sharply as markets reacted to statements that the Strait of Hormuz is fully open again. With the “war premium” in oil deflating, investors appear to be repricing near-term upstream cash flows and energy-sector earnings expectations.

Details:

Crude oil prices dropped more than 10% after public statements indicated commercial transit through the Strait of Hormuz had reopened, reducing fears of prolonged supply disruptions.

The Strait of Hormuz is a critical chokepoint for global seaborne crude flows, so even incremental changes in perceived shipping risk can move oil benchmarks quickly.

Large integrated producers like Exxon typically trade with oil and refined-product price expectations, so a fast oil selloff can translate into an outsized, same-day equity move.

This could also reflect positioning unwind after recent volatility in energy markets tied to Middle East headlines, amplifying the stock’s decline.

Sources:

Associated Press, Axios, Exxon Mobil (Investor Relations)

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$XOM Insider Trading Activity

$XOM insiders have traded $XOM stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $XOM stock by insiders over the last 6 months:

DARRIN L TALLEY (VP - Corp Strategic Planning) has made 0 purchases and 7 sales selling 17,460 shares for an estimated $2,395,656.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$XOM Hedge Fund Activity

We have seen 2,082 institutional investors add shares of $XOM stock to their portfolio, and 1,828 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 38,130,356 shares (-70.4%) from their portfolio in Q4 2025, for an estimated $4,588,607,041
NORGES BANK added 6,185,309 shares (+10.8%) to their portfolio in Q4 2025, for an estimated $744,340,085
JPMORGAN CHASE & CO removed 4,661,338 shares (-6.2%) from their portfolio in Q4 2025, for an estimated $560,945,414
FMR LLC added 4,365,511 shares (+3.4%) to their portfolio in Q4 2025, for an estimated $525,345,593
PACER ADVISORS, INC. removed 4,344,733 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $522,845,169
BARCLAYS PLC removed 4,037,620 shares (-37.7%) from their portfolio in Q4 2025, for an estimated $485,887,190
LAZARD ASSET MANAGEMENT LLC removed 3,677,926 shares (-63.3%) from their portfolio in Q4 2025, for an estimated $442,601,614

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$XOM Congressional Stock Trading

Members of Congress have traded $XOM stock 8 times in the past 6 months. Of those trades, 5 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $XOM stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $100,000 on 02/10 and 1 sale worth up to $100,000 on 01/09.
REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 2 purchases worth up to $30,000 on 02/04, 02/02 and 0 sales.
SENATOR JOHN BOOZMAN purchased up to $15,000 on 01/08.
REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$XOM Analyst Ratings

Wall Street analysts have issued reports on $XOM in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Wells Fargo issued a "Overweight" rating on 02/02/2026
Barclays issued a "Overweight" rating on 01/21/2026
Freedom Capital Markets issued a "Sell" rating on 01/06/2026
Jefferies issued a "Buy" rating on 12/10/2025
UBS issued a "Buy" rating on 12/01/2025
Piper Sandler issued a "Overweight" rating on 11/10/2025
Scotiabank issued a "Sector Outperform" rating on 11/03/2025

To track analyst ratings and price targets for $XOM, check out Quiver Quantitative's $XOM forecast page.

$XOM Price Targets

Multiple analysts have issued price targets for $XOM recently. We have seen 17 analysts offer price targets for $XOM in the last 6 months, with a median target of $163.0.

Here are some recent targets:

Devin McDermott from Morgan Stanley set a target price of $171.0 on 04/17/2026
Jason Gabelman from TD Cowen set a target price of $172.0 on 04/10/2026
Sam Margolin from Wells Fargo set a target price of $185.0 on 04/09/2026
Biraj Borkhataria from RBC Capital set a target price of $180.0 on 04/09/2026
Lloyd Byrne from Jefferies set a target price of $184.0 on 04/09/2026
Ryan Todd from Piper Sandler set a target price of $182.0 on 04/09/2026
Arun Jayaram from JP Morgan set a target price of $170.0 on 04/09/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.